We assumed that Peptibody vaccine with dramatic immunogenicity could neutralize bFGF and VEGFA in tumor microenvironment via the anti‐bFGF and anti‐VEGFA antibodies it elicited. The gene discussed is FGF2; the disease is neoplasm.